InvestorsHub Logo

tredenwater2

12/08/21 10:55 AM

#339190 RE: Ortiz #339159

“Labeling is also a hurdle in the approval process. Anavex will have a lot of work to do to get the labeling approved for each indication that AVXL 2-73 may treat in patients that vary in age, size, condition, genetic make up, etc.”



Dont forget absorbtion rates. If you “flush” 60% of the drug out you might need a higher dose. Also the slow titration process would allow for patients to gradually work up to maximum “personal” tolerated dosing. I see a 10 mg capsul to start and after a few months changing to a 20 or 30 mg long term.

Fill my sippy cup with 20 mg please!